Study Complete
Sponsor ID
20030210
Phase 2 AMG 714 in Rheumatoid Arthritis
Study Details
Twelve week treatment of AMG 714 in RA patients who failed at least one DMARD, followed by a 3 month observational period.
Protocol Summary
Primary Outcome Measures
Not Available
Secondary Outcome Measures
Not Available
Locations
No locations found.